XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,389 | -21.3% | 128,487 | -11.3% | 0.21% | -15.2% |
| Q2 2023 | $5,578 | +305.7% | 144,877 | +277.2% | 0.24% | +273.8% |
| Q1 2023 | $1,375 | -4.2% | 38,407 | +5.5% | 0.06% | -18.8% |
| Q4 2022 | $1,436 | -99.9% | 36,416 | -19.5% | 0.08% | -19.2% |
| Q3 2022 | $1,633,000 | +103.4% | 45,246 | +71.4% | 0.10% | +65.0% |
| Q2 2022 | $803,000 | +117.6% | 26,404 | +118.7% | 0.06% | +150.0% |
| Q1 2022 | $369,000 | – | 12,074 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |